


Georgios (George) Papafotiou
Titel: | Dr. (PhD) |
Aktuelle Position: | Akademischer Mitarbeiter am Institut für Biochemie |
Einrichtung: | Institut für Anatomie, IAG MMKE |
Adresse: |
Campus Brandenburg an der Havel
Haus 11, 2. OG, R. 3.01
Hochstraße 29
14770 Brandenburg |
Telefon: | +49 3381 41-2668 |
E-Mail: | georgios.papafotiou@mhb-fontane.de |
Forschung: | Molekularbiologie, Tumorimmunologie |
Lehrschwerpunkt(e): | Molekularbiologie, Gene editing |
Publikationen
Meine besten fünf Publikationen:
-
Immisch L, Papafotiou G, Popp O, Mertins P, Blankenstein T, Willimsky G. H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma. J. Immunother. Cancer 2022;10:e005535.
-
Papafotiou G, Paraskevopoulou V, Vasilaki E, Kanaki Z, Paschalidis N, Klinakis A. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nature communications 2016;7:11914–11.
-
Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M, Dereli-Oz A, Kocylowski M, Pateras IS, Evangelou K, Kotsinas A, Orsolic I, Bursac S, Cokaric-Brdovcak M, Zoumpourlis V, Kletsas D, Papafotiou G, Klinakis A, Volarevic S, Gu W, Bartek J, Halazonetis TD & Gorgoulis VG . Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. Nature Cell Biology 2013;15:1–14.
-
Papafotiou G, Oehler S, Savakis C & Bourtzis K. Regulation of Wolbachia ankyrin domain encoding genes in Drosophila gonads. Research in microbiology 2011;162:764–772.
-
Soutoglou E, Papafotiou G, Katrakili N & Talianidis I. Transcriptional activation by hepato-cyte nuclear factor-1 requires synergism between multiple coactivator proteins. The Journal of biological chemistry 2000;275:12515–12520.